National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Leuprolide
Synonyms

6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)

6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig)

Leuprorelin

LEUPROLIDE

Leuprolide

leuprolide

Definitions

A synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62042

ALT_DEFINITION

The active ingredient in a drug used to treat symptoms of advanced prostate cancer. It is also used to treat early puberty in children and certain gynecologic conditions. It is being studied in the treatment of other conditions and types of cancer. Leuprolide blocks the body from making testosterone (a male hormone) and estradiol (a female hormone). It may stop the growth of prostate cancer cells that need testosterone to grow. It is a type of gonadotropin-releasing hormone analog.

CAS_Registry

53714-56-0

CHEBI_ID

CHEBI:6427

Chemical_Formula

C59H84N16O12

code

C62042

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C192234

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

Contributing_Source

CTRP

FDA

GDC

HemOnc

OORO

DEFINITION

A synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression.

Display_Name

Leuprolide

FDA_UNII_Code

EFY6W0M8TG

FULL_SYN

6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)

6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig)

Leuprorelin

LEUPROLIDE

Leuprolide

leuprolide

Has_Salt_Form

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C190727

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C179722

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1319

Has_Target

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38910

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Leuprolide

Legacy Concept Name

Leuprolide_Base

Maps_To

Leuprolide

NSC Number

377526

Preferred_Name

Leuprolide

prefixIRI

Thesaurus:C62042

Semantic_Type

Amino Acid, Peptide, or Protein

Pharmacologic Substance

UMLS_CUI

C0085272

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1910

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://sbmi.uth.tmc.edu/ontology/ochv#15531 OCHV LOOM
http://purl.obolibrary.org/obo/OMIT_0017176 OMIT LOOM
http://purl.bioontology.org/ontology/CSP/4000-0227 CRISP LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.776.641.650.405.740.320.400 RH-MESH LOOM
http://purl.bioontology.org/ontology/RXNORM/42375 RXNORM LOOM
http://www.phoc.org.cn/pmo/class/PMO_00019103 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/NCIT_C62042 BERO LOOM
http://purl.jp/bio/4/id/200906006950029492 IOBC LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 GSSO LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_6427 ODNAE LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D016729 RH-MESH LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000147889 ODAE LOOM
https://go.drugbank.com/drugs/DB00007 MDM LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.644.400.400.740.320.400 RH-MESH LOOM
http://www.drugbank.ca/drugs/DB00007 FTC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D06.472.699.327.740.320.400 RH-MESH LOOM
http://purl.bioontology.org/ontology/NDDF/004751 NDDF LOOM
http://purl.bioontology.org/ontology/LNC/LP172752-0 LOINC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.644.456.460.480 RH-MESH LOOM
http://purl.obolibrary.org/obo/MESH_D016729 BERO LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147889 NDFRT LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/397198002 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/VANDF/4019800 VANDF LOOM
http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#leuprorelin PCAO LOOM
http://purl.bioontology.org/ontology/MESH/D016729 MESH LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0085272 OCHV LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.644.548.365.740.320.400 RH-MESH LOOM